In addition, treatment of HuH7 human HCC cells with EGCG decreases the expression of both phosphorylated and non-phosphorylated vascular endothelial growth factor (VEGF) receptor-2 (VEGFR-2) proteins [59]. Here, VEGFA is linked to hepatocellular carcinoma.